Trial Profile
A prospective randomized double-blind study Intranasal dexmedetomidine versus intranasal S-ketamine for children age 1 – 3 years for procedural sedation and analgesia in pediatric emergency department.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2024
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Esketamine
- Indications Sedation
- Focus Therapeutic Use
- 13 Mar 2024 Status changed from recruiting to discontinued, according to a European Clinical Trials Database record.
- 15 Jun 2017 New trial record